Federal Register of Legislation - Australian Government

Primary content

PB 109 of 2010 Determinations/Health as amended, taking into account amendments up to National Health (Price and Special Patient Contribution) Amendment Determination 2018 (No. 1) (PB 2 of 2018)
This Determination revokes National Health Act 1953 - Determination under section 85B - Price determinations and special patient contributions (No. PB 72 of 2010) and provides for price determinations in relation to pharmaceutical items for which the Minister and the responsible person have not been able to make a price argeement and the circumstances in which the Commonwealth will pay the special patient contribution resulting from these price determinations.
Administered by: Health
Registered 01 Feb 2018
Start Date 01 Feb 2018
End Date 31 Mar 2018
Table of contents.

Commonwealth Coat of Arms of Australia

National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

made under section 85B of the

National Health Act 1953

Compilation No. 62

Compilation date:                              1 February 2018

Includes amendments up to:            PB 2 of 2018

Registered:                                         1 February 2018

 

About this compilation

This compilation

This is a compilation of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010) that shows the text of the law as amended and in force on 1 February 2018 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.

Self-repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

  

  

  


Contents

1............ Name of Determination................................................................................................. 1

4............ Definitions..................................................................................................................... 1

5............ Determined price........................................................................................................... 1

6............ Claimed price................................................................................................................. 1

7............ Commonwealth payment of special patient contribution................................................ 2

Schedule 1—Determined and Claimed Prices                                                            3

Schedule 2—Pharmaceutical benefits for which the Commonwealth will pay the special patient contribution                                                                         32

Endnotes                                                                                                                                                               34

Endnote 1—About the endnotes                                                                                                      34

Endnote 2—Abbreviation key                                                                                                          35

Endnote 3—Legislation history                                                                                                       36

Endnote 4—Amendment history                                                                                                     40

 


 

 

1  Name of Determination

             (1)  This Determination is the National Health (Price and Special Patient Contribution) Determination 2010.

             (2)  This Determination may also be cited as PB 109 of 2010.

4  Definitions

             (1)  In this Determination:

Act means the National Health Act 1953.

approved ex‑manufacturer price has the same meaning as in subsection 84(1) of the Act.

base‑priced drug in relation to a brand of a pharmaceutical item mentioned in Schedule 2 (the relevant brand), means all brands of pharmaceutical items that have:

                     (a)  the same drug as the relevant brand; or

                     (b)  a drug in the same therapeutic group as that drug; and

for which no price is determined under section 85B of the Act.

pack quantity has the same meaning as in subsection 84(1) of the Act.

Note:          The Minister may determine one or more pack quantities for a brand of a pharmaceutical item under subsection 84AK(2) of the Act. The quantities determined are the quantities in manufacturer’s PBS packs.

pricing quantity has the same meaning as in subsection 84(1) of the Act.

Note:          Subsection 84AK(1) of the Act provides that the pricing quantity of a brand of a pharmaceutical item is the lowest pack quantity of any brand of the pharmaceutical item.

special patient contribution has the meaning given by subsection 85B(5) of the Act.

5  Determined price

                   For subsection 85B(2) of the Act, the amount that is, for the purposes of Part VII of the Act, taken to be the appropriate maximum price for the pricing quantity of a brand of a pharmaceutical item mentioned in Schedule 1, is the price for the brand mentioned in the column headed ‘Determined Price’ for the pricing quantity mentioned in the column headed ‘Pricing Quantity/Pack Quantity’.

6  Claimed price

                   For subsection 85B(3) of the Act, the amount that is, for the purposes of Part VII of the Act, taken to be the price claimed by the responsible person for a pack quantity of a brand of a pharmaceutical item mentioned in Schedule 1, is the price for the brand mentioned in the column headed ‘Claimed Price’ for the pack quantity mentioned in the column headed ‘Pricing Quantity/Pack Quantity’.

7  Commonwealth payment of special patient contribution

             (1)  For subsection 85B(4) of the Act, the circumstances in which the Commonwealth is to pay the special patient contribution for a brand of a pharmaceutical item are:

                     (a)  the brand of pharmaceutical item is mentioned in Schedule 2; and

                     (b)  the brand has been prescribed in a circumstance mentioned for the brand in Schedule 2; and

                     (c)  the prescription has been authorised by the Chief Executive Medicare in accordance with subsection (2) or (3).

             (2)  If the circumstance in which the brand is prescribed is a circumstance determined under paragraph 85(7)(b) of the Act, the prescription is taken to be authorised if:

                     (a)  the circumstance requires compliance with authority required procedures for prescribing the brand; and

                     (b)  the authority required procedures have been complied with.

             (3)  In any other case, a prescription is taken to be authorised if the prescription has been submitted and authorised in the way provided for in authority required procedures mentioned in an instrument made under section 85 of the Act.

             (4)  For this section, the pharmaceutical item is the listed drug mentioned in Schedule 2:

                     (a)  in the form mentioned in Schedule 2 for the listed drug; and

                     (b)  with the manner of administration mentioned in Schedule 2 for the form of the listed drug.


Schedule 1Determined and Claimed Prices

  

 

Listed Drug

Form

Manner of Administration

Brand

Pricing Quantity/Pack Quantity

Determined
Price
$

Claimed
 Price
$

Aciclovir

Tablet 200 mg

Oral

Zovirax 200 mg

25

6.34

-

 

 

 

 

90

-

23.67

Alendronic acid with colecalciferol

Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol

Oral

Fosamax Plus

4

6.37

10.09

 

Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol

Oral

Fosamax Plus 70 mg/140 mcg

4

6.37

10.09

Alendronic acid with colecalciferol and calcium

Pack containing 4 tablets containing alendronic acid 70 mg (as alendronate sodium) with 140 micrograms colecalciferol and 48 tablets calcium 500 mg (as carbonate)

Oral

Fosamax Plus
D-Cal

1

10.92

12.67

Allopurinol

Tablet 100 mg

Oral

Zyloprim

100

2.26

-

 

 

 

 

200

-

7.75

 

Tablet 300 mg

Oral

Zyloprim

60

3.27

6.51

Amitriptyline

Tablet containing amitriptyline hydrochloride 10 mg

Oral

Endep 10

50

2.33

4.15

 

Tablet containing amitriptyline hydrochloride 25 mg

Oral

Endep 25

50

2.51

4.33

 

Tablet containing amitriptyline hydrochloride 50 mg

Oral

Endep 50

50

2.88

4.70

Amlodipine

Tablet 5 mg (as besylate)

Oral

Norvasc

30

0.83

9.38

 

Tablet 10 mg (as besylate)

Oral

Norvasc

30

1.47

10.03

Amlodipine with atorvastatin

Tablet 5 mg amlodipine (as besylate) with 10 mg atorvastatin (as calcium)

Oral

Caduet 5/10

30

2.25

5.04

 

Tablet 5 mg amlodipine (as besylate) with 20 mg atorvastatin (as calcium)

Oral

Caduet 5/20

30

2.93

5.72

 

Tablet 5 mg amlodipine (as besylate) with 40 mg atorvastatin (as calcium)

Oral

Caduet 5/40

30

3.78

6.57

 

Tablet 5 mg amlodipine (as besylate) with 80 mg atorvastatin (as calcium)

Oral

Caduet 5/80

30

5.05

7.84

 

Tablet 10 mg amlodipine (as besylate) with 10 mg atorvastatin (as calcium)

Oral

Caduet 10/10

30

2.89

5.68

 

Tablet 10 mg amlodipine (as besylate) with 20 mg atorvastatin (as calcium)

Oral

Caduet 10/20

30

3.57

6.36

 

Tablet 10 mg amlodipine (as besylate) with 40 mg atorvastatin (as calcium)

Oral

Caduet 10/40

30

4.42

7.21

 

Tablet 10 mg amlodipine (as besylate) with 80 mg atorvastatin (as calcium)

Oral

Caduet 10/80

30

5.69

8.48

Amoxycillin

Capsule 250 mg (as trihydrate)

Oral

Amoxil

20

1.30

4.55

 

Capsule 500 mg (as trihydrate)

Oral

Amoxil

20

1.60

5.10

 

Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL

Oral

Amoxil

1

1.28

4.50

 

Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL

Oral

Amoxil Forte

1

1.59

4.90

 

Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL

Oral

Amoxil

1

3.42

3.92

 

Tablet 1 g (as trihydrate)

Oral

Maxamox

14

1.47

2.47

Amoxycillin with Clavulanic Acid

Powder for oral suspension containing 400 mg amoxycillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL

Oral

Augmentin Duo 400

1

1.90

6.40

 

Tablet containing 500 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)

Oral

Augmentin Duo

10

2.30

6.83

 

Tablet containing 875 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)

Oral

Augmentin Duo forte

10

2.58

8.38

Atenolol

Tablet 50 mg

Oral

Tenormin

30

1.06

3.33

Betamethasone

Cream 200 micrograms (as valerate) per g, 100 g

Application

Betnovate 1/5

1

7.20

9.98

 

 

 

Celestone-M

1

7.20

9.52

 

Cream 500 micrograms (as dipropionate) per g, 15 g

Application

Diprosone

1

5.43

7.71

 

Cream 500 micrograms (as valerate) per g, 15 g

Application

Betnovate 1/2

1

1.61

3.99

 

Ointment 500 micrograms (as dipropionate) per g, 15 g

Application

Diprosone

1

5.43

7.71

Betaxolol

Eye drops, solution, 5 mg (as hydrochloride) per mL, 5 mL

Application to the eye

Betoptic

1

6.75

11.18

Bisacodyl

Suppositories 10 mg, 10

Rectal

Dulcolax

1

3.92

4.32

Bisoprolol

Tablet containing bisoprolol fumarate 2.5 mg

Oral

Bicor

28

6.28

12.51

 

Tablet containing bisoprolol fumarate 5 mg

Oral

Bicor

28

7.84

14.07

 

Tablet containing bisoprolol fumarate 10 mg

Oral

Bicor

28

9.80

16.03

Brimonidine

Eye drops containing brimonidine tartrate 2 mg per mL, 5 mL

Application to the eye

Alphagan

1

11.10

12.42

Brinzolamide

Eye drops 10 mg per mL, 5 mL

Application to the eye

Azopt

1

13.23

17.67

Calcitriol

Capsule 0.25 microgram

Oral

Rocaltrol

100

14.99

17.12

Candesartan

Tablet containing candesartan cilexetil 4 mg

Oral

Atacand

30

0.43

4.15

 

Tablet containing candesartan cilexetil 8 mg

Oral

Atacand

30

1.29

5.01

 

Tablet containing candesartan cilexetil 16 mg

Oral

Atacand

30

3.84

7.56

 

Tablet containing candesartan cilexetil 32 mg

Oral

Atacand

30

4.64

10.81

Candesartan with Hydrochlorothiazide

Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg

Oral

Atacand Plus 16/12.5

30

4.12

7.84

 

Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg

Oral

Atacand Plus 32/12.5

30

4.82

13.42

 

Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg

Oral

Atacand Plus 32/25

30

5.59

12.80

Captopril

Tablet 12.5 mg

Oral

Zedace

90

3.12

6.79

 

Tablet 25 mg

Oral

Capoten

90

4.51

8.85

 

 

 

Zedace

90

4.51

8.18

 

Tablet 50 mg

Oral

Capoten

90

8.89

12.52

 

 

 

Zedace

90

8.89

12.56

Carbamazepine

Tablet 100 mg

Oral

Tegretol 100

100

5.47

6.86

 

Tablet 200 mg

Oral

Tegretol 200

100

9.13

10.51

Carbomer

Eye gel 2 mg per g, 10 g

Application to the eye

Viscotears

1

2.62

6.20

Carmellose

Eye drops containing carmellose sodium 5 mg per mL, single dose units 0.4 mL, 30

Application to the eye

Cellufresh

1

6.37

8.63

 

Eye drops containing carmellose sodium 10 mg per mL, single dose units 0.4 mL, 30

Application to the eye

Celluvisc

1

6.37

8.63

Cefaclor

Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

Oral

Ceclor

1

3.11

7.85

 

Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL

Oral

Ceclor

1

3.31

8.25

 

Tablet (sustained release) 375 mg (as monohydrate)

Oral

Ceclor CD

10

3.50

9.32

Cephalexin

Capsule 250 mg (anhydrous)

Oral

Keflex

20

1.59

5.09

 

Capsule 500 mg (anhydrous)

Oral

Keflex

20

1.73

6.82

 

Granules for oral suspension 125 mg per 5 mL, 100 mL

Oral

Keflex

1

1.82

5.68

 

Granules for oral suspension 250 mg per 5 mL, 100 mL

Oral

Keflex

1

2.10

7,39

Ciprofloxacin

Eye drops 3 mg (as hydrochloride) per mL, 5 mL

Application to the eye

Ciloxan

1

8.92

10.95

 

Tablet 250 mg (as hydrochloride)

Oral

Ciproxin 250

14

2.98

4.59

 

Tablet 500 mg (as hydrochloride)

Oral

Ciproxin 500

14

5.82

8.08

Citalopram

Tablet 20 mg (as hydrobromide)

Oral

Cipramil

28

1.21

8.15

Clarithromycin

Tablet 250 mg

Oral

Klacid

14

2.75

6.00

Clindamycin

Capsule 150 mg (as hydrochloride)

Oral

Dalacin C

24

6.39

14.39

Clomipramine

Tablet containing clomipramine hydrochloride 25 mg

Oral

Anafranil 25

50

5.52

9.63

Clonazepam

Tablet 2 mg

Oral

Rivotril

100

9.96

12.10

 

Tablet 500 micrograms

Oral

Rivotril

100

5.29

7.00

Codeine with Paracetamol

Tablet containing codeine phosphate 30 mg with paracetamol 500 mg

Oral

Panadeine Forte

20

1.26

3.21

Colchicine

Tablet 500 micrograms

Oral

Colgout

30

3.70

6.40

Cyproterone

Tablet containing cyproterone acetate 50 mg

Oral

Androcur

20

13.32

15.55

 

 

 

 

50

-

34.36

 

Tablet containing cyproterone acetate 100 mg

Oral

Androcur-100

50

51.88

53.19

Dexamethasone with Framycetin and Gramicidin

Ear drops containing dexamethasone 500 micrograms (as sodium metasulfobenzoate), framycetin sulfate 5 mg and gramicidin 50 micrograms per mL, 8 mL

Application to the ear

Sofradex

1

2.85

4.39

Diazepam

Tablet 2 mg

Oral

Antenex 2

50

1.23

4.01

 

Tablet 5 mg

Oral

Valium

50

1.29

3.33

Diclofenac

Tablet (enteric coated) containing diclofenac sodium 25 mg

Oral

Voltaren 25

50

1.37

2.97

 

Tablet (enteric coated) containing diclofenac sodium 50 mg

Oral

Voltaren 50

50

1.91

5.12

Digoxin

Tablet 62.5 micrograms

Oral

Lanoxin-PG

200

3.24

5.62

 

Tablet 250 micrograms

Oral

Lanoxin

100

3.47

5.85

Diltiazem

Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg

Oral

Cardizem CD

30

6.25

8.02

 

Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg

Oral

Cardizem CD

30

8.45

10.22

 

Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg

Oral

Cardizem CD

30

11.08

12.84

 

Tablet containing diltiazem hydrochloride 60 mg

Oral

Cardizem

90

5.64

7.40

 

 

 

Vasocardol

90

5.64

7.40

Diphenoxylate with Atropine

Tablet containing diphenoxylate hydrochloride 2.5 mg with atropine sulfate 25 micrograms

Oral

Lomotil

20

1.66

3.06

Donepezil

Tablet containing donepezil hydrochloride 5 mg

Oral

Aricept

28

9.36

12.78

 

Tablet containing donepezil hydrochloride 10 mg

Oral

Aricept

28

9.36

17.73

Dorzolamide with timolol

Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL

Application to the eye

Cosopt

1

12.08

13.01

Doxepin

Capsule 10 mg (as hydrochloride)

Oral

Sinequan

50

2.69

9.20

 

Capsule 25 mg (as hydrochloride)

Oral

Sinequan

50

2.79

9.30

Doxycycline

Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)

Oral

Doryx

7

1.36

4.11

 

 

 

Mayne Pharma Doxycycline

7

1.36

2.79

 

 

 

Doryx

21

-

12.45

 

 

 

Mayne Pharma Doxycycline

21

-

7.07

 

Capsule 50 mg (as hydrochloride) (containing enteric coated pellets)

Oral

Doryx

25

2.17

6.83

 

 

 

Mayne Pharma Doxycycline

25

2.17

4.58

Duloxetine

Capsule 30 mg (as hydrochloride)

Oral

Cymbalta

28

3.86

5.63

 

Capsule 60 mg (as hydrochloride)

Oral

Cymbalta

28

5.51

7.28

Enalapril

Tablet containing enalapril maleate 10 mg

Oral

Renitec

30

2.87

8.83

 

Tablet containing enalapril maleate 20 mg

Oral

Renitec 20

30

3.65

9.60

Enalapril with Hydrochlorothiazide

Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg

Oral

Renitec Plus 20/6

30

4.99

11.50

Eprosartan

Tablet 400 mg (as mesylate)

Oral

Teveten

28

5.75

9.00

 

Tablet 600 mg (as mesylate)

Oral

Teveten

28

14.41

17.66

Erythromycin

Capsule 250 mg (containing enteric coated pellets)

Oral

Eryc

25

4.45

6.80

 

Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL

Oral

E.E.S. 200

1

4.46

6.66

 

Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL

Oral

E.E.S. Granules

1

5.68

7.90

Escitalopram

Tablet 10 mg (as oxalate)

Oral

Lexapro

28

1.95

9.85

 

Tablet 20 mg (as oxalate)

Oral

Lexapro

28

1.97

10.19

Exemestane

Tablet 25 mg

Oral

Aromasin

30

51.62

55.34

Felodipine

Tablet 2.5 mg (extended release)

Oral

Plendil ER

30

2.61

4.55

 

Tablet 5 mg (extended release)

Oral

Plendil ER

30

3.75

5.69

 

Tablet 10 mg (extended release)

Oral

Plendil ER

30

6.79

8.73

Fluconazole

Capsule 50 mg

Oral

Diflucan

28

9.90

15.48

Fluoxetine

Capsule 20 mg (as hydrochloride)

Oral

Prozac 20

28

3.45

4.55

 

Tablet, dispersible, 20 mg (as hydrochloride)

Oral

Prozac Tab

28

3.45

4.55

Fluvoxamine

Tablet containing fluvoxamine maleate 50 mg

Oral

Luvox

30

5.26

8.52

 

Tablet containing fluvoxamine maleate 100 mg

Oral

Luvox

30

7.97

11.23

Frusemide

Tablet 20 mg

Oral

Lasix-M

50

0.78

1,46

 

Tablet 40 mg

Oral

Lasix

100

1.56

3.28

Gliclazide

Tablet 60 mg (modified release)

Oral

Diamicron 60mg MR

60

6.73

12.89

Glimepiride

Tablet 1 mg

Oral

Amaryl

30

0.90

2.98

 

Tablet 2 mg

Oral

Amaryl

30

1.72

3.75

 

Tablet 3 mg

Oral

Amaryl

30

2.19

4.22

 

Tablet 4 mg

Oral

Amaryl

30

2.70

4.73

Glipizide

Tablet 5 mg

Oral

Minidiab

100

6.34

14.25

Glyceryl Trinitrate

Tablets 600 micrograms, 100

Buccal/sublingual

Anginine Stabilised

1

6.80

9.18

Hydrocortisone

Cream containing hydrocortisone acetate 10 mg per g, 50 g

Application

Sigmacort

1

1.73

3.92

 

Ointment containing hydrocortisone acetate 10 mg per g, 50 g

Application

Sigmacort

1

1.73

3.92

Hypromellose

Eye drops 3 mg per mL, 15 mL

Application to the eye

Genteal

1

3.12

7.15

Hypromellose with Carbomer 980

Ocular lubricating gel 3 mg-2 mg per g, 10 g

Application to the eye

Genteal gel

1

3.12

7.15

Hypromellose with Dextran

Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL

Application to the eye

Tears Naturale

1

3.29

6.69

Imiquimod

Cream 50 mg per g, 2 g, 2

Application

Aldara Pump

1

70.25

74.48

 

Cream 50 mg per g, 250 mg single use sachets, 12

Application

Aldara

1

70.25

72.37

Indapamide

Tablet containing indapamide hemihydrate 1.5 mg (sustained release)

Oral

Natrilix SR

90

7.17

12.89

 

Tablet containing indapamide hemihydrate 2.5 mg

Oral

Natrilix

90

4.91

11.03

Indomethacin

Capsule 25 mg

Oral

Indocid

50

2.60

4.48

Ipratropium

Nebuliser solution containing ipratropium bromide 250 micrograms (anhydrous) in 1 mL single dose units, 30

Inhalation

Atrovent

1

7.55

7.78

 

Nebuliser solution containing ipratropium bromide 500 micrograms (anhydrous) in 1 mL single dose units, 30

Inhalation

Atrovent Adult

1

8.92

9.15

Irbesartan

Tablet 75 mg

Oral

Avapro

30

1.20

2.97

 

 

 

Karvea

30

1.20

2.97

 

Tablet 150 mg

Oral

Avapro

30

1.71

3.48

 

 

 

Karvea

30

1.71

3.48

 

Tablet 300 mg

Oral

Avapro

30

3.43

5.20

 

 

 

Karvea

30

3.43

5.20

Irbesartan with hydrochlorothiazide

Tablet 150 mg-12.5 mg

Oral

Avapro HCT 150/12.5

30

1.96

3.73

 

 

 

Karvezide 150/12.5

30

1.96

3.73

 

Tablet 300 mg-12.5 mg

Oral

Avapro HCT 300/12.5

30

3.60

5.37

 

 

 

Karvezide 300/12.5

30

3.60

5.37

 

Tablet 300 mg-25 mg

Oral

Avapro HCT 300/25

30

3.92

5.68

 

 

 

Karvezide 300/25

30

3.92

5.68

Isosorbide Mononitrate

Tablet 60 mg (sustained release)

Oral

Imdur Durule

30

3.42

6.56

 

 

 

Monodur 60 mg

30

3.42

5.73

 

Tablet 120 mg (sustained release)

Oral

Imdur 120 mg

30

6.81

9.94

Ketoprofen

Capsule 200 mg (sustained release)

Oral

Orudis SR 200

28

10.26

12.04

Labetalol

Tablet containing labetalol hydrochloride 100 mg

Oral

Trandate

100

12.32

15.58

 

Tablet containing labetalol hydrochloride 200 mg

Oral

Trandate

100

12.32

15.58

Lamivudine

Tablet 100 mg

Oral

Zeffix

28

34.70

35.30

Lamotrigine

Tablet 25 mg

Oral

Lamictal

56

5.18

6.68

 

Tablet 50 mg

Oral

Lamictal

56

8.63

9.97

 

Tablet 100 mg

Oral

Lamictal

56

14.37

15.77

 

Tablet 200 mg

Oral

Lamictal

56

24.15

25.54

Lansoprazole

Tablet 15 mg (orally disintegrating)

Oral

Zoton FasTabs

28

2.92

6.62

 

Tablet 30 mg (orally disintegrating)

Oral

Zoton FasTabs

28

5.24

8.95

Lercanidipine

Tablet containing lercanidipine hydrochloride 10 mg

Oral

Zanidip

28

1.95

5.21

 

Tablet containing lercanidipine hydrochloride 20 mg

Oral

Zanidip

28

3.25

6.50

Levodopa with Carbidopa

Tablet 100 mg-25 mg (anhydrous)

Oral

Sinemet 100/25

100

25.77

31.12

Levonorgestrel with Ethinyloestradiol

Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets

Oral

Levlen ED

4

5.68

8.71

 

 

 

Nordette 28

4

5.68

16.43

 

Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets

Oral

Triphasil 28

4

7.18

19.27

 

 

 

Triquilar ED

4

7.18

17.79

Lisinopril

Tablet 5 mg

Oral

Zestril

30

2.01

5.08

 

Tablet 10 mg

Oral

Zestril

30

3.01

6.08

 

Tablet 20 mg

Oral

Zestril

30

3.79

6.86

Loperamide

Capsule containing loperamide hydrochloride 2 mg

Oral

Imodium

12

1.39

1.99

Medroxyprogesterone

Injection containing medroxyprogesterone acetate 150 mg in 1 mL

Injection

Depo-Provera

1

13.14

19.65

 

Tablet containing medroxyprogesterone acetate 5 mg

Oral

Provera

56

7.44

13.67

 

Tablet containing medroxyprogesterone acetate 10 mg

Oral

Provera

30

6.39

12.62

 

 

 

 

100

-

27.53

Meloxicam

Capsule 7.5 mg

Oral

Mobic

30

2.60

4.93

 

Capsule 15 mg

Oral

Mobic

30

3.80

6.13

 

Tablet 7.5 mg

Oral

Mobic

30

2.60

4.93

 

Tablet 15 mg

Oral

Mobic

30

3.80

6.13

Metformin

Tablet containing metformin hydrochloride 500 mg

Oral

Diabex

100

2.50

7.11

 

Tablet (extended release) containing metformin hydrochloride 500 mg

Oral

Diabex XR

120

4.01

8.61

 

Tablet containing metformin hydrochloride 850 mg

Oral

Diabex 850

60

2.50

7.11

 

Tablet containing metformin hydrochloride 1 g

Oral

Diabex 1000

90

4.36

8.97

 

Tablet (extended release) containing metformin hydrochloride 1 g

Oral

Diabex XR 1000

60

4.01

8.61

Methyldopa

Tablet 250 mg

Oral

Aldomet

100

8.18

11.05

Methylprednisolone

Injection containing methylprednisolone acetate 40 mg in 1 mL

Injection

Depo-Medrol

5

10.58

13.01

Metoclopramide

Tablet containing metoclopramide hydrochloride 10 mg

Oral

Maxolon

25

1.05

2.83

Metoprolol

Tablet containing metoprolol tartrate 50 mg

Oral

Betaloc

100

1.77

5.26

 

 

 

Lopresor 50

100

1.77

3.44

 

Tablet containing metoprolol tartrate 100 mg

Oral

Betaloc

60

2.26

5.76

 

 

 

Lopresor 100

60

2.26

3.93

Metronidazole

Tablet 200 mg

Oral

Flagyl

21

1.18

3.04

 

Tablet 400 mg

Oral

Flagyl

21

2.77

4.63

Minocycline

Tablet 50 mg (as hydrochloride)

Oral

Minomycin-50

60

6.98

8.51

Mirtazapine

Tablet 15 mg (orally disintegrating)

Oral

Avanza SolTab

30

3.85

8.27

 

 

 

Remeron SolTab

30

3.85

8.27

 

Tablet 30 mg

Oral

Avanza

30

3.35

8.00

 

Tablet 30 mg (orally disintegrating)

Oral

Avanza SolTab

30

5.13

9.55

 

 

 

Remeron SolTab

30

5.13

9.55

 

Tablet 45 mg (orally disintegrating)

Oral

Avanza SolTab

30

7.72

12.14

 

 

 

Remeron SolTab

30

7.72

12.14

Moclobemide

Tablet 150 mg

Oral

Aurorix

60

9.06

11.85

 

Tablet 300 mg

Oral

Aurorix 300 mg

60

15.13

17.92

Mometasone

Cream containing mometasone furoate 1 mg per g, 15 g

Application

Elocon Alcohol Free

1

3.08

6.36

 

Lotion containing mometasone furoate 1 mg per g, 30 mL

Application

Elocon

1

4.86

8.15

 

Ointment containing mometasone furoate 1 mg per g, 15 g

Application

Elocon

1

3.08

6.36

Montelukast

Tablet, chewable, 4 mg (as sodium)

Oral

Singulair

28

6.65

9.44

 

Tablet, chewable, 5 mg (as sodium)

Oral

Singulair

28

6.26

9.05

Naproxen

Tablet 250 mg

Oral

Naprosyn

50

3.38

4.42

 

Tablet 500 mg

Oral

Naprosyn

50

4.99

6.04

 

Tablet 1 g (sustained release)

Oral

Naprosyn SR1000

28

6.10

7.14

 

Tablet 750 mg (sustained release)

Oral

Naprosyn SR750

28

4.58

5.56

 

Tablet containing naproxen sodium 550 mg

Oral

Anaprox 550

50

5.13

6.89

Naratriptan

Tablet 2.5 mg (as hydrochloride)

Oral

Naramig

2

7.49

8.55

Nifedipine

Tablet 10 mg

Oral

Adalat 10

60

4.64

6.17

 

Tablet 20 mg

Oral

Adalat 20

60

5.71

7.84

 

Tablet 30 mg (controlled release)

Oral

Adalat Oros 30

30

6.41

8.75

 

Tablet 60 mg (controlled release)

Oral

Adalat Oros 60

30

8.05

10.53

Nitrazepam

Tablet 5 mg

Oral

Mogadon

25

1.50

2.65

Nizatidine

Capsule 150 mg

Oral

Tazac

60

9.71

15.86

 

Capsule 300 mg

Oral

Tazac

30

9.71

15.86

Norethisterone with Ethinyloestradiol

Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets

Oral

Brevinor

4

8.12

17.22

 

Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets

Oral

Brevinor-1

4

8.12

17.22

Olanzapine

Tablet 2.5 mg

Oral

Zyprexa

28

2.58

5.37

 

Tablet 5 mg

Oral

Zyprexa

28

5.10

7.89

 

Tablet 7.5 mg

Oral

Zyprexa

28

7.73

10.52

 

Tablet 10 mg

Oral

Zyprexa

28

10.30

13.09

 

Wafer 5 mg

Oral

Zyprexa Zydis

28

5.10

7.89

 

Wafer 10 mg

Oral

Zyprexa Zydis

28

10.30

13.09

 

Wafer 15 mg

Oral

Zyprexa Zydis

28

15.45

18.24

 

Wafer 20 mg

Oral

Zyprexa Zydis

28

20.60

23.39

Olmesartan

Tablet containing olmesartan medoxomil 20 mg

Oral

Olmetec

30

7.43

10.69

 

Tablet containing olmesartan medoxomil 40 mg

Oral

Olmetec

30

15.76

19.02

Omeprazole

Tablet 20 mg (as magnesium)

Oral

Losec Tablets

30

4.12

6.97

Ondansetron

Wafer 4 mg

Oral

Zofran Zydis

4

3.41

5.69

 

 

 

Zofran Zydis

10

-

10.81

 

Wafer 8 mg

Oral

Zofran Zydis

4

5.35

7.63

 

 

 

Zofran Zydis

10

-

15.66

Oxazepam

Tablet 15 mg

Oral

Serepax

25

1.32

3.79

 

Tablet 30 mg

Oral

Serepax

25

1.00

3.17

Paraffin

Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g

Application to the eye

Refresh Night Time

1

11.47

13.18

Paroxetine

Tablet 20 mg (as hydrochloride)

Oral

Aropax

30

3.18

5.58

Perindopril

Tablet containing perindopril arginine 2.5 mg

Oral

Coversyl 2.5mg

30

1.43

7.31

 

Tablet containing perindopril arginine 5 mg

Oral

Coversyl 5mg

30

2.66

8.25

 

Tablet containing perindopril arginine 10 mg

Oral

Coversyl 10mg

30

4.07

10.10

Perindopril with amlodipine

Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besylate)

Oral

Coveram 5/5

30

3.49

9.18

 

Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besylate)

Oral

Coveram 5/10

30

4.13

10.11

 

Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besylate)

Oral

Coveram 10/5

30

4.90

11.03

 

Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besylate)

Oral

Coveram 10/10

30

5.54

11.96

Perindopril with indapamide

Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 mg

Oral

Coversyl Plus LD 2.5mg/0.625mg

30

1.84

8.24

 

Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg

Oral

Coversyl Plus 5mg/1.25mg

30

3.48

9.18

 

Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg

Oral

Perindo Combi 4/1.25

30

3.48

6.21

Piroxicam

Capsule 10 mg

Oral

Feldene

50

4.68

12.12

 

Capsule 20 mg

Oral

Feldene

25

4.45

11.89

 

Dispersible tablet 20 mg

Oral

Feldene-D

25

4.45

11.89

Potassium chloride

Tablet 600 mg (sustained release)

Oral

Slow-K

100

3.80

5.20

Pravastatin

Tablet containing pravastatin sodium 10 mg

Oral

Cholstat 10

30

1.43

4.18

 

Tablet containing pravastatin sodium 10 mg

Oral

Pravachol

30

1.43

4.17

 

Tablet containing pravastatin sodium 20 mg

Oral

Pravachol

30

2.27

5.02

 

Tablet containing pravastatin sodium 40 mg

Oral

Pravachol

30

3.53

6.33

 

Tablet containing pravastatin sodium 80 mg

Oral

Pravachol

30

5.43

8.23

Prednisolone

Oral solution 5 mg (as sodium phosphate) per mL, 30 mL

Oral

Redipred

1

6.70

8.88

 

Tablet 1 mg

Oral

Panafcortelone

100

2.38

3.31

Prednisone

Tablet 1 mg

Oral

Panafcort

100

2.33

3.26

Prochlorperazine

Tablet containing prochlorperazine maleate 5 mg

Oral

Stemetil

25

0.90

3.69

Propranolol

Tablet containing propranolol hydrochloride 10 mg

Oral

Deralin 10

100

2.56

5.34

 

 

 

Inderal

100

2.56

6.05

 

Tablet containing propranolol hydrochloride 40 mg

Oral

Deralin 40

100

2.81

5.59

 

 

 

Inderal

100

2.81

6.30

Quinapril

Tablet 5 mg (as hydrochloride)

Oral

Accupril

30

2.91

6.82

 

Tablet 10 mg (as hydrochloride)

Oral

Accupril

30

3.71

7.62

 

Tablet 20 mg (as hydrochloride)

Oral

Accupril

30

4.58

8.48

Rabeprazole

Tablet containing rabeprazole sodium 10 mg (enteric coated)

Oral

Pariet

28

2.83

6.50

 

Tablet containing rabeprazole sodium 20 mg (enteric coated)

Oral

Pariet

30

2.83

6.50

Ranitidine

Tablet 150 mg (as hydrochloride)

Oral

Zantac

60

3.22

4.78

 

Tablet 300 mg (as hydrochloride)

Oral

Zantac

30

3.22

4.78

 

Tablet, effervescent, 150 mg (as hydrochloride)

Oral

Zantac

30

1.81

2.35

Roxithromycin

Tablet 150 mg

Oral

Rulide

10

2.31

3.81

 

Tablet 300 mg

Oral

Rulide

5

2.31

3.81

Salbutamol

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20

Inhalation

Ventolin Nebules

20

2.48

3.11

 

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30

Inhalation

Asmol 2.5 uni-dose

1

3.72

3.95

 

Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20

Inhalation

Ventolin Nebules

1

2.61

3.23

 

Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30

Inhalation

Asmol 5 uni-dose

1

3.92

4.15

 

Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)

Inhalation by mouth

Ventolin CFC-free

1

3.45

5.10

Sertraline

Tablet 50 mg (as hydrochloride)

Oral

Zoloft

30

1.57

6.97

 

Tablet 100 mg (as hydrochloride)

Oral

Zoloft

30

1.57

6.97

Simvastatin

Tablet 10 mg

Oral

Lipex 10

30

1.04

6.00

 

 

 

Zocor

30

1.04

6.00

 

Tablet 20 mg

Oral

Lipex 20

30

1.51

8.48

 

 

 

Zocor

30

1.51

8.48

 

Tablet 40 mg

Oral

Lipex 40

30

2.17

9.14

 

 

 

Zocor

30

2.17

9.14

 

Tablet 80 mg

Oral

Lipex 80

30

3.10

10.97

 

 

 

Zocor

30

3.10

10.97

Sotalol

Tablet containing sotalol hydrochloride 80 mg

Oral

Sotacor

60

2.99

7.01

 

Tablet containing sotalol hydrochloride 160 mg

Oral

Sotacor

60

6.43

10.45

Spironolactone

Tablet 25 mg

Oral

Aldactone

100

4.67

11.64

 

Tablet 100 mg

Oral

Aldactone

100

18.36

25.33

Sulfasalazine

Tablet 500 mg (enteric coated)

Oral

Salazopyrin-EN

100

20.15

22.01

Sumatriptan

Tablet 50 mg (as succinate)

Oral

Imigran

2

2.40

4.35

 

 

 

 

4

 

8.70

 

Tablet (fast disintegrating) 50 mg (as succinate)

Oral

Imigran FDT

2

2.40

4.35

 

 

 

 

4

 

8.70

Telmisartan

Tablet 40 mg

Oral

Micardis

28

1.94

4.44

 

Tablet 80 mg

Oral

Micardis

28

5.61

8.11

Telmisartan with amlodipine

Tablet 40 mg-5 mg (as besylate)

Oral

Twynsta

28

2.71

5.21

 

Tablet 40 mg-10 mg (as besylate)

Oral

Twynsta

28

3.31

5.81

 

Tablet 80 mg-5 mg (as besylate)

Oral

Twynsta

28

6.38

8.88

 

Tablet 80 mg-10 mg (as besylate)

Oral

Twynsta

28

6.98

9.48

Telmisartan with hydrochlorothiazide

Tablet 40 mg-12.5 mg

Oral

Micardis Plus 40/12.5 mg

28

2.12

4.62

 

Tablet 80 mg-12.5 mg

Oral

Micardis Plus 80/12.5 mg

28

5.29

7.79

 

Tablet 80 mg-25 mg

Oral

Micardis Plus 80/25 mg

28

5.76

8.26

Temazepam

Tablet 10 mg

Oral

Normison

25

1.00

4.24

Thyroxine

Tablet containing 50 micrograms anhydrous thyroxine sodium

Oral

Oroxine

200

13.71

15.49

 

Tablet containing 75 micrograms anhydrous thyroxine sodium

Oral

Oroxine

200

14.23

16.07

 

Tablet containing 100 micrograms anhydrous thyroxine sodium

Oral

Oroxine

200

14.20

15.99

 

Tablet containing 200 micrograms anhydrous thyroxine sodium

Oral

Oroxine

200

16.65

18.44

Tinidazole

Tablet 500 mg

Oral

Fasigyn

4

3.53

9.77

Tramadol

Capsule containing tramadol hydrochloride 50 mg

Oral

Tramal

20

1.86

4.11

 

Tablet (sustained release) containing tramadol hydrochloride 100 mg

Oral

Tramal SR 100

20

2.24

6.42

 

Tablet (sustained release) containing tramadol hydrochloride 150 mg

Oral

Tramal SR 150

20

3.00

8.00

 

Tablet (sustained release) containing tramadol hydrochloride 200 mg

Oral

Tramal SR 200

20

3.66

9.32

Trandolapril

Capsule 500 micrograms

Oral

Gopten

28

1.96

5.22

 

Capsule 1 mg

Oral

Gopten

28

3.69

6.95

 

Capsule 2 mg

Oral

Gopten

28

4.45

7.70

 

Capsule 4 mg

Oral

Gopten

28

8.36

11.61

Triamcinolone

Cream containing triamcinolone acetonide 200 micrograms per g, 100 g

Application

Aristocort 0.02%

1

3.23

4.75

 

Ointment containing triamcinolone acetonide 200 micrograms per g, 100 g

Application

Aristocort 0.02%

1

3.23

4.75

Triamcinolone with Neomycin, Gramicidin and Nystatin

Ear drops containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 7.5 mL

Application to the ear

Kenacomb Otic

1

3.78

5.36

 

Ear ointment containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 5 g

Application to the ear

Kenacomb Otic

1

1.42

3.00

Trimethoprim

Tablet 300 mg

Oral

Triprim

7

1.58

5.00

Trimethoprim with Sulfamethoxazole

Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL

Oral

Septrin

1

2.03

7.32

 

Tablet 160 mg-800 mg

Oral

Bactrim DS

10

1.76

3.78

 

 

 

Septrin Forte

10

1.76

5.64

Valaciclovir

Tablet 500 mg (as hydrochloride)

Oral

Valtrex

10

4.42

5.47

 

 

 

Valtrex

30

 

15.36

 

 

 

Valtrex

42

 

20.67

 

 

 

Valtrex

100

 

44.64

Valproic Acid

Tablet (enteric coated) containing sodium valproate 200 mg

Oral

Epilim EC

100

5.46

6.39

 

Tablet (enteric coated) containing sodium valproate 500 mg

Oral

Epilim EC

100

10.81

11.74

Verapamil

Tablet containing verapamil hydrochloride 80 mg

Oral

Isoptin

100

6.95

10.20

 

Tablet containing verapamil hydrochloride 180 mg (sustained release)

Oral

Isoptin 180 SR

30

5.61

8.86

 

Tablet containing verapamil hydrochloride 240 mg (sustained release)

Oral

Isoptin SR

30

7.48

10.73

Zolmitriptan

Tablet 2.5 mg

Oral

Zomig

2

5.52

6.81

 

Schedule 2Pharmaceutical benefits for which the Commonwealth will pay the special patient contribution

(section 7)

  

Listed Drug

Form

Manner of Administration

Brand

Circumstances

Amoxycillin

Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL

Oral

Amoxil

Treatment of infections suspected or proven to be due to a susceptible organism in patients who require a liquid formulation and in whom the syrup formulations are unsuitable. 

Eprosartan

Tablet 400 mg (as mesylate)

Oral

Teveten

Adverse effects occurring with all of the base‑priced drugs.

Drug interactions occurring with all of the base‑priced drugs. 

Drug interactions expected to occur with all of the base‑priced drugs.

Transfer to a base‑priced drug would cause patient confusion resulting in problems with compliance. 

 

Tablet 600 mg (as mesylate)

Oral

Teveten

Adverse effects occurring with all of the base-priced drugs.

Drug interactions occurring with all of the base-priced drugs.

Drug interactions expected to occur with all of the base-priced drugs.

Transfer to a base-priced drug would cause patient confusion resulting in problems with compliance.

Naratriptan

Tablet 2.5 mg (as hydrochloride)

Oral

Naramig

Migraine attack in a patient where attacks in the past have usually failed to respond to analgesics, and where adverse events have occurred with other suitable PBS‑listed drugs. 

Migraine attack in a patient where attacks in the past have usually failed to respond to analgesics, and where drug interactions have occurred with other suitable PBS‑listed drugs.

Migraine attack in a patient where attacks in the past have usually failed to respond to analgesics, and where drug interactions are expected to occur with other suitable PBS-listed drugs.

Migraine attack in a patient where attacks in the past have usually failed to respond to analgesics, and where transfer to another suitable PBS‑listed drug would cause patient confusion resulting in problems with compliance.

Migraine attack in a patient where attacks in the past have usually failed to respond to analgesics, and where transfer to another suitable PBS‑listed drug is likely to result in adverse clinical consequences.   


Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Editorial changes

The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.

If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.

If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history.

 

 

 

 

Endnote 2—Abbreviation key

 

ad = added or inserted

o = order(s)

am = amended

Ord = Ordinance

amdt = amendment

orig = original

c = clause(s)

par = paragraph(s)/subparagraph(s)

C[x] = Compilation No. x

    /sub‑subparagraph(s)

Ch = Chapter(s)

pres = present

def = definition(s)

prev = previous

Dict = Dictionary

(prev…) = previously

disallowed = disallowed by Parliament

Pt = Part(s)

Div = Division(s)

r = regulation(s)/rule(s)

ed = editorial change

reloc = relocated

exp = expires/expired or ceases/ceased to have

renum = renumbered

    effect

rep = repealed

F = Federal Register of Legislation

rs = repealed and substituted

gaz = gazette

s = section(s)/subsection(s)

LA = Legislation Act 2003

Sch = Schedule(s)

LIA = Legislative Instruments Act 2003

Sdiv = Subdivision(s)

(md) = misdescribed amendment can be given

SLI = Select Legislative Instrument

    effect

SR = Statutory Rules

(md not incorp) = misdescribed amendment

Sub‑Ch = Sub‑Chapter(s)

    cannot be given effect

SubPt = Subpart(s)

mod = modified/modification

underlining = whole or part not

No. = Number(s)

    commenced or to be commenced

 

Endnote 3—Legislation history

 

Name

Registration

Commencement

Application, saving and transitional provisions

PB 109 of 2010

30 Nov 2010 (F2010L03136)

1 Dec 2010 (s 2)

 

PB 6 of 2011

28 Jan 2011 (F2011L00165)

1 Feb 2011 (s 2)

PB 15 of 2011

23 Feb 2011 (F2011L00298)

1 Mar 2011 (s 2)

PB 25 of 2011

25 Mar 2011 (F2011L00490)

s 1–3: 26 Mar 2011
Sch 1: 1 Apr 2011
(s 2(1))
Sch 2: 2 Apr 2011
(s 2(2))

PB 43 of 2011

15 June 2011 (F2011L01051)

1 July 2011 (s 2)

PB 50 of 2011

27 July 2011 (F2011L01546)

1 Aug 2011 (s 2)

PB 58 of 2011

29 Aug 2011 (F2011L01763)

1 Sept 2011 (s 2)

PB 75 of 2011

26 Oct 2011 (F2011L02131)

1 Nov 2011 (s 2)

PB 84 of 2011

28 Nov 2011 (F2011L02476)

1 Dec 2011 (s 2)

PB 2 of 2012

13 Feb 2012 (F2012L00272)

1 Mar 2012 (s 2)

PB 14 of 2012

30 Mar 2012 (F2012L00723)

s 1–3 and Sch 1: 1 Apr 2011 (s 2(1))
Sch 2: 1 Apr 2012
(s 2(2))

PB 28 of 2012

26 Apr 2012 (F2012L00936)

1 May 2012 (s 2)

PB 45 of 2012

25 July 2012 (F2012L01599)

1 Aug 2012 (s 2)

PB 61 of 2012

15 Aug 2012 (F2012L01682)

1 Sept 2012v

PB 72 of 2012

27 Sept 2012 (F2012L01952)

1 Oct 2012 (s 2)

PB 94 of 2012

29 Nov 2012 (F2012L02284)

1 Dec 2012 (s 2)

PB 109 of 2012

18 Dec 2012 (F2012L02511)

1 Jan 2013 (s 2)

PB 2 of 2013

10 Jan 2013 (F2013L00040)

1 Feb 2013 (s 2)

PB 15 of 2013

26 Mar 2013 (F2013L00559)

1 Apr 2013 (s 2)

PB 22 of 2013

23 Apr 2013 (F2013L00678)

1 May 2013 (s 2)

PB 41 of 2013

29 July 2013 (F2013L01457

1 Aug 2013 (s 2)

PB 54 of 2013

15 Aug 2013 (F2013L01579)

1 Sept 2013 (s 2)

PB 62 of 2013

10 Sept 2013 (F2013L01681)

1 Oct 2013 (s 2)

PB 75 of 2013

28 Nov 2013 (F2013L02007)

1 Dec 2013 (s 2)

PB 89 of 2013

20 Dec 2013 (F2013L02169)

1 Jan 2014 (s 2)

PB 2 of 2014

10 Jan 2014 (F2014L00052)

1 Feb 2014 (s 2)

PB 18 of 2014

26 Mar 2014 (F2014L00356)

1 Apr 2014 (s 2)

PB 28 of 2014

11 Apr 2014 (F2014L00400)

1 May 2014 (s 2)

PB 37 of 2014

21 May 2014 (F2014L00589)

1 June 2014 (s 2)

PB 53 of 2014

31 July 2014 (F2014L01063)

1 Aug 2014 (s 2)

PB 73 of 2014

26 Sept 2014 (F2014L01289)

1 Oct 2014 (s 2)

PB 89 of 2014

27 Nov 2014 (F2014L01597)

1 Dec 2014 (s 2)

PB 11 of 2015

25 Feb 2015 (F2015L00208)

1 Mar 2015 (s 2)

PB 27 of 2015

25 Mar 2015 (F2015L00333)

1 Apr 2015 (s 2)

PB 40 of 2015

24 Apr 2015 (F2015L00590)

1 May 2015 (s 2)

PB 48 of 2015

29 May 2015 (F2015L00763)

1 June 2015 (s 2)

PB 69 of 2015

31 July 2015 (F2015L01204)

1 Aug 2015 (s 2)

PB 79 of 2015

28 Aug 2015 (F2015L01352)

1 Sept 2015 (s 2)

PB 91 of 2015

30 Sept 2015 (F2015L01537)

1 Oct 2015 (s 2)

PB 102 of 2015

28 Oct 2015 (F2015L01703)

1 Nov 2015 (s 2)

PB 108 of 2015

30 Nov 2015 (F2015L01874)

1 Dec 2015 (s 2)

PB 118 of 2015

24 Dec 2015 (F2015L02131)

1 Jan 2016 (s 2)

PB 2 of 2016

1 Feb 2016 (F2016L00073)

1 Feb 2016 (s 2)

PB 19 of 2016

1 Apr 2016 (F2016L00478)

1 Apr 2016 (s 2)

PB 30 of 2016

29 Apr 2016 (F2016L00600)

1 May 2016 (s 2)

PB 42 of 2016

30 May 2016 (F2016L00861)

1 June 2016 (s 2)

PB 63 of 2016

19 July 2016 (F2016L01189)

1 Aug 2016 (s 2)

PB 73 of 2016

18 Aug 2016 (F2016L01305)

1 Sept 2016 (s 2)

PB 82 of 2016

30 Sept 2016 (F2016L01563)

1 Oct 2016 (s 2)

PB 91 of 2016

31 Oct 2016 (F2016L01688)

1 Nov 2016 (s 2)

PB 98 of 2016

30 Nov 2016 (F2016L01839)

1 Dec 2016 (s 2)

PB 2 of 2017

25 Jan 2017 (F2017L00072)

1 Feb 2017 (s 2)

PB 16 of 2017

30 Mar 2017 (F2017L00357)

1 Apr 2017 (s 2)

PB 27 of 2017

28 Apr 2017 (F2017L00482)

1 May 2017 (s 2)

PB 35 of 2017

31 May 2017 (F2017L00618)

1 June 2017 (s 2)

PB 56 of 2017

25 July 2017 (F2017L00950)

1 Aug 2017 (s 2)

PB 63 of 2017

30 Aug 2017 (F2017L01111)

1 Sept 2017 (s 2)

PB 72 of 2017

26 Sept 2017 (F2017L01251)

1 Oct 2017 (s 2)

PB 85 of 2017

24 Oct 2017 (F2017L01384)

1 Nov 2017 (s 2)

PB 93 of 2017

29 Nov 2017 (F2017L01546)

1 Dec 2017 (s 2)

PB 102 of 2017

18 Dec 2017 (F2017L01642)

1 Jan 2018 (s 2)

PB 2 of 2018

24 Jan 2018 (F2018L00058)

1 Feb 2018 (s 2)

 

Endnote 4—Amendment history

 

Provision affected

How affected

s 2........................................

rep LA s 48D

s 3........................................

rep LA s 48C

s 4........................................

am PB 72 of 2012

s 5........................................

rs PB 72 of 2012

s 6........................................

rs PB 72 of 2012

s 7........................................

am PB 58 of 2011; PB 72 of 2012

Schedule 1

 

Schedule 1...........................

rs PB 6 of 2011

 

am PB 15, 25, 43, 50, 58, 75 and 84 of 2011; PB 2, 14, 28, 45 and 61 of 2012

 

rs PB 72 of 2012

 

am PB 94 and 109 of 2012; PB 2, 15, 22, 41, 54, 62, 75 and 89 of 2013; PB 2, 18, 28, 37, 53, 73 and 89 of 2014; PB 11, 27, 40, 48, 69, 79, 91, 102, 108 and 118 of 2015; PB 2, 19, 30 and 42 of 2016; PB 63 of 2016; PB 73 of 2016; PB 82 of 2016; PB 91 of 2016; PB 98 of 2016; PB 2 of 2017; PB 16 of 2017; PB 27 of 2017; PB 35 of 2017; PB 56 of 2017; PB 63 of 2017; PB 72 of 2017; PB 85 of 2017; PB 93 of 2017; PB 102 of 2017; PB 2 of 2018

Schedule 2

 

Schedule 2...........................

am PB 15 and 25 of 2011; PB 14 of 2012; PB 22, 41 and 62 of 2013; PB 53 of 2014; PB 98 of 2016